RaySearch Laboratories AB (publ) announced that Keimyung University Dongsan Medical Centre (DSMC) in South Korea has selected the treatment planning system RayStation and oncology information system RayCare to enable advanced cancer treatment at its new proton centre. Installation is scheduled to begin in the second quarter of 2028, with first patient treatments expected by the end of 2029.

DSMC's Comprehensive Cancer Centre is at the forefront of patient-centred cancer care and will be the first top-tier general hospital in South Korea to introduce the ProTom Radiance 330 proton therapy system. This development will make DSMC the country's third proton centre, after the National Cancer Centre and Samsung Medical Centre, and the first located outside a metropolitan area, broadening access to cutting-edge cancer treatment for patients in the region.

By combining RayStation and RayCare, the centre will integrate treatment planning and oncology information management into one workflow, including advanced functionalities such as synchrotron-based proton pencil beam scanning therapy. This technique allows for highly precise radiation delivery while minimising exposure to surrounding healthy tissue. It is particularly effective for cancers in sensitive areas such as the head and neck, spinal cord, and in pediatric patients, helping reduce side effects and improve patients' quality of life.

CHI-HEUM CHO, President, Keimyung University Dongsan Medical Centre: "We are pleased to introduce RayStation and RayCare at the new proton therapy centre at Keimyung University Dongsan Medical Centre. These advanced systems will enable the establishment of a more precise and efficient cancer treatment framework, setting new standards for oncology care that are competitive not only within Korea but also on a global scale."